newsfilter
← Latest News
Business Wire·

ImmunoGen Announces Webcast of Presentation and Q&A at Upcoming Jefferies Healthcare Conference

ImmunoGen, Inc. (NASDAQ:IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today announced that Mark Enyedy, President and CEO, and Anna Berkenblit, Chief Medical